Phibro Animal Health Corp. - Ordinary Shares - Class A

Phibro Animal Health Corp. - Ordinary Shares - Class A

PAHC - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.58B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Phibro Animal Health Corp. - Ordinary Shares - Class APhibro Animal Health Corp. - Ordinary Shares - Class A15.81.24%26%12
$-4.84

Current Fair Value

112.6% downside

Overvalued by 112.6% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$1.58 Billion
Enterprise Value$2.30 Billion
Annual dividend$0.48
Dividend yield1.24%
Earnings per Share$2.46
Beta0.42
Outstanding Shares40,600,000

Return

Return on Equity25.87%ROE
Return on Assets6.64%
Return on Invested Capital15.93%

Valuation & Multiples

P/E Ratio15.77P/E Ratio
PEG60.56PEG
Price to Sales1.04Price to Sales
Price to Book Ratio4.26Price to Book Ratio
Enterprise Value to Revenue1.52
Enterprise Value to EBIT12.2
Enterprise Value to Net Income23
Total Debt to Enterprise0.34
Debt to Equity2.05Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
September 2, 2026
EPS Estimate
$0.72
Consensus analyst estimate
Revenue Estimate
$386.49 M
Consensus analyst estimate

Next Earnings Call

Expected Date
November 4, 2026
EPS Estimate
$0.78
Consensus analyst estimate
Revenue Estimate
$382.42 M
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.0000▼ 378.95%
Total Calls-▼ 100.00%
Total Puts-▼ 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.61%▼ 51.80%
Total Invested$8.82M▼ 98.68%
Investors Holding32▼ 183.00%

About Phibro Animal Health Corp.

CEO: Jack Bendheim

Phibro Animal Health Insider Information FAQ

Stockcircle tracks 3 top investors with a current 13F position in Phibro Animal Health. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 1 top investor increased or opened positions and 3 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle shows 1 open-market insider purchase and 14 open-market insider sales for Phibro Animal Health in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.